"Scotland Cancer Treatment Center is located in Laurinburg, North Carolina. It delivers a broad range of diagnostic and treatment options in a comfortable, community-based setting. Some services include chemotherapy, infusion therapy, blood transfusions, bone-marrow biopsy, comprehensive assessments, management of ongoing subspecialty medical issues, and more."

During the past decade, Scotland Memorial Hospital-Laurinburg Cancer Center conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 5 clinical trials were completed, i.e. on average, 45.5% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 4 clinical trials were completed. i.e. 400% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Scotland Memorial Hospital-Laurinburg Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 6 trials, followed by "Alliance for Clinical Trials in Oncology" with 3 trials sponsored, "Duke University" with 2 trials sponsored, "SWOG Cancer Research Network" with 2 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 2 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Scotland Memorial Hospital-Laurinburg Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 7 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "Canadian Cancer Trials Group" with 1 trials as a collaborator, "Duke Cancer Institute" with 1 trials as a collaborator and "NRG Oncology" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Scotland Memorial Hospital-Laurinburg Cancer Center" are "Stage IB Lung Non-Small Cell Carcinoma AJCC v7" (3 trials), "Stage II Lung Non-Small Cell Cancer AJCC v7" (3 trials), "Stage IIIA Lung Non-Small Cell Cancer AJCC v7" (3 trials), "Recurrent Breast Carcinoma" (2 trials) and "Stage IIA Lung Non-Small Cell Carcinoma AJCC v7" (2 trials). Many other conditions were trialed in "Scotland Memorial Hospital-Laurinburg Cancer Center" in a lesser frequency.

Most popular intervention types in "Scotland Memorial Hospital-Laurinburg Cancer Center" are "Other" (12 trials), "Drug" (11 trials), "Biological" (4 trials), "Procedure" (2 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (6 trials), "Quality-of-Life Assessment" (4 trials), "Clinical Observation" (3 trials), "Biospecimen Collection" (2 trials) and "Carboplatin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Scotland Memorial Hospital-Laurinburg Cancer Center" are 11 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Scotland Memorial Hospital-Laurinburg Cancer Center". undefined are not yet recruiting, 3 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Scotland Memorial Hospital-Laurinburg Cancer Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Scotland Memorial Hospital-Laurinburg Cancer Center, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".